4.5 Article

Daxx silencing sensitizes cells to multiple apoptotic pathways

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 23, Issue 20, Pages 7108-7121

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.23.20.7108-7121.2003

Keywords

-

Funding

  1. NCI NIH HHS [CA87074, R01 CA087074-01, R01 CA087074-02, R01 CA087074-04, R01 CA087074-06, R01 CA087074, R01 CA087074-05, R01 CA087074-03] Funding Source: Medline

Ask authors/readers for more resources

Daxx is a nuclear protein involved in apoptosis and transcriptional repression, and it interacts with the death receptor Fas, promyelocytic leukemia protein (PML), and several transcriptional repressors. The function of Daxx in apoptosis is controversial because opposite results were obtained in transient overexpression and genetic knockout studies. Furthermore, the roles of PML and transcriptional repression in Daxx-regulated apoptosis are currently unknown. In this study, we investigated the role of Daxx in Fas- and stress-induced apoptosis by small interfering RNA-mediated Daxx silencing in mammalian cells. Daxx silencing had no apparent cytotoxic effects on mammalian cells within 72 h. Intriguingly, Daxx silencing strongly sensitized cells to Fas- and stress-induced apoptosis, which was accompanied by caspase activation, cytochrome c release, and Jun N-terminal kinase activation. Consistently, endogenous Daxx was degraded rapidly upon induction of apoptosis by stress or anti-Fas antibody. Finally, PML silencing had no effect on Daxx silencing-mediated apoptotic events, while caspase gene expression was upregulated in the absence of Daxx. These data strongly suggest that Daxx may inhibit Fas and stress-mediated apoptosis by suppressing proapoptotic gene expression outside of PML domains.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available